Image-guided percutaneous needle biopsy for the diagnosis of cancer of unknown primary.
anesthesia
cancer
complications
needle biopsy
radiology
Journal
Asia-Pacific journal of clinical oncology
ISSN: 1743-7563
Titre abrégé: Asia Pac J Clin Oncol
Pays: Australia
ID NLM: 101241430
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
12
06
2021
accepted:
27
01
2022
pubmed:
4
3
2022
medline:
21
9
2022
entrez:
3
3
2022
Statut:
ppublish
Résumé
This study aimed to assess the efficacy of image-guided percutaneous needle biopsy in patients with suspected cancer of unknown primary. We conducted a retrospective observational study. Among 291 patients with suspected cancer of unknown primary who were referred to our institution between April 2011 and March 2014, 89 who underwent image-guided percutaneous needle biopsy and 27 who underwent surgical biopsy were defined as the image-guided percutaneous needle biopsy group and the surgical group, respectively. Patient backgrounds, diagnostic yields, promptness of biopsy, general anesthesia rates, and severe complication rates were compared between the two groups. There was no significant difference in the patient backgrounds of the two groups. The diagnostic yields were 98.9% (95% confidence interval, 93.9%-99.8%) in the image-guided percutaneous needle biopsy group and 100% (95% confidence interval, 87.5%-100%) in the surgical biopsy group (no significant difference; p = 1.0). The mean time to biopsy was significantly shorter (6.5 days vs. 21.3 days; p < .0001) and general anesthesia was used in significantly fewer patients (0% vs. 40.7%; p < .0001) in the image-guided percutaneous needle biopsy group. There was no significant difference in the rate of serious complications between the two groups (p = 1.0). As a biopsy procedure for patients with suspected cancer of unknown primary, image-guided percutaneous needle biopsy is equally diagnostic and safe for surgical biopsy and might be preferable to surgical biopsy in terms of promptness and not requiring general anesthesia.
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e479-e485Informations de copyright
© 2022 John Wiley & Sons Australia, Ltd.
Références
Pavilidis N, Fizazi K. Carcinoma of unknown primary (CUP). Crit Rev Oncol Hematol. 2009;69:271-278.
Pavlidis N. Cancer of unknown primary: biological and clinical characteristics. Ann Oncol. 2003;14(Suppl 3):iii11-iii18. https://doi.org/10.1093/annonc/mdg742.
Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 2003;39:1990-2005. https://doi.org/10.1016/s0959-8049(03)00547-1.
Conner JR, Hornick JL. Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry. Adv Anat Pathol. 2015;22:149-167. https://doi.org/10.1097/PAP.0000000000000069.
Bahrami A, Truong LD, Ro JY. Undifferentiated tumor: true identity by immunohistochemistry. Arch Pathol Lab Med. 2008;132:326-348.
Varadhachary GR, Raber MN. Cancer of unknown primary site. N Engl J Med. 2014;371:757-765. https://doi.org/10.1056/NEJMra1303917.
Hainsworth JD, Greco FA. Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care. Virchows Arch. 2014;464:393-402. https://doi.org/10.1007/s00428-014-1545-20.
Fizazi K, Greco FA, Pavlidis N, Daugaard G, Oien K, Pentheroudakis G. Cancers of unknown primary site: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v133-8. https://doi.org/10.1093/annonc/mdq193.
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Accessed 1 May, 2020. Occult primary (Cancer of unknown primary). Version 2. 2020. https://www.nccn.org/professionals/physician_gls/pdf/occult.pdf.
Hainsworth JD, Greco FA. Treatment of patients with cancer of an unknown primary site. N Engl J Med. 1993;329:257-263. https://doi.org/10.1056/NEJM199307223290407.
Heck SL, Blom P, Berstad A. Accuracy and complications in computed tomography fluoroscopy-guided needle biopsies of lung masses. Eur Radiol. 2006;16:1387-1392. https://doi.org/10.1007/s00330-006-0152-2.
Maturen KE, Nghiem HV, Caoili EM, Higgins EG, Wolf JS Jr, Wood DP Jr. Renal mass core biopsy: accuracy and impact on clinical management. AJR Am J Roentgenol. 2007;188:563-570. https://doi.org/10.2214/AJR.06.0220.
Vieillard MH, Boutry N, Chastanet P, Duquesnoy B, Cotten A, Cortet B. Contribution of percutaneous biopsy to the definite diagnosis in patients with suspected bone tumor. Joint Bone Spine. 2005;72:53-60. https://doi.org/10.1016/j.jbspin.2004.03.008.
Vadvala HV, Furtado VF, Kambadakone A, Frenk NE, Mueller PR, Arellano RS. Image-guided percutaneous omental and mesenteric biopsy: assessment of technical success rate and diagnostic yield. J Vasc Interv Radiol. 2017;28:1569-1576. https://doi.org/10.1016/j.jvir.2017.07.001.
Agid R, Sklair-Levy M, Bloom AI, et al. CT-guided biopsy with cutting-edge needle for the diagnosis of malignant lymphoma: experience of 267 biopsies. Clin Radiol. 2003;58:143-147. https://doi.org/10.1053/crad.2002.1061.
Agarwal PP, Seely JM, Matzinger FR, et al. Pleural mesothelioma: sensitivity and incidence of needle track seeding after image-guided biopsy versus surgical biopsy. Radiology. 2006;241:589-594. https://doi.org/10.1148/radiol.2412051020.
Guimaraes MD, Marchiori E, Odisio BC, et al. Functional imaging with diffusion-weighted MRI for lung biopsy planning: initial experience. World J Surg Oncol. 2014;12:203. https://doi.org/10.1186/1477-7819-12-203.
Tomiyama N, Yasuhara Y, Nakajima Y, et al. CT-guided needle biopsy of lung lesions: a survey of severe complication based on 9783 biopsies in Japan. Eur J Radiol. 2006;59:60-64. https://doi.org/10.1016/j.ejrad.2006.02.001.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213. https://doi.org/10.1097/01.sla.0000133083.54934.ae.
Gupta S, Wallace MJ, Cardella JF, Kundu S, Miller DL, Rose SC. Quality improvement guidelines for percutaneous needle biopsy. J Vasc Interv Radiol. 2010;21:969-975. https://doi.org/10.1016/j.jvir.2010.01.011.
Hewitt MJ, Anderson K, Hall GD, et al. Women with peritoneal carcinomatosis of unknown origin: efficacy of image-guided biopsy to determine site-specific diagnosis. BJOG. 2007;114:46-50. https://doi.org/10.1111/j.1471-0528.2006.01176.x.
Shimizu I, Okazaki Y, Takeda W, et al. Use of percutaneous image-guided coaxial core-needle biopsy for diagnosis of intraabdominal lymphoma. Cancer Med. 2014;3:1336-1341. https://doi.org/10.1002/cam4.224.